PDS Biotechnology Corp — Form 8-K
Filed August 19, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 18/100
What the filing says
PDS Biotechnology Corp filed an 8-K on 2026-08-19 reporting Item 5.02 (officer/director changes and compensatory arrangements) effective 2026-08-13. The filing provides no specific dollar amounts, percentage changes, share counts, or concrete details of any compensation modifications—only that a compensatory arrangement for certain officers was adjusted.
Why this rating
Routine officer compensation disclosure; no quantified impact stated; standard 8-K administrative filing common for all public companies.
Extracted items
See more from August 19, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.